Skip to main content
HCPCS J0670 · Level II · Part B drug

J0670: mepivacaine hydrochloride (Polocaine, Polocaine-Mpf, Polocaine - Mpf), HCPCS Level II J code

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: ASP payment limits: October 2026 (effective October 1, 2026); NCCI MUE tables: 2026 Q4 (effective October 1, 2026); NCCI PTP edits: v323r0 (2026 Q4) (effective October 1, 2026); OPPS Addendum B: October 2026 (effective October 1, 2026); ASC Addendum BB (covered ancillary services): October 2026 (effective October 1, 2026). Next CMS release: January 1, 2027 (quarterly update).

Key facts for J0670

Billing unit
10 ML
Inj mepivacaine hcl/10 ml
ASP payment limit
$4.367
October 2026; +5.3% vs July 2026
Practitioner MUE
10
MAI 3
OPPS status
SI N
NCCI exposure
1548 col-2 pairs
100% allow a modifier
Coverage articles
0
none list this code

TL;DR

HCPCS J0670 is the Level II code for Injection, mepivacaine hydrochloride, per 10 ml, billed per 10 ML. The Medicare Part B ASP payment limit for October 2026 is $4.367 per billing unit, up 5.3% from July 2026. The practitioner MUE allows up to 10 units per date of service (MAI 3), so a full 10-unit day is $43.67 at the current limit. Under OPPS it carries status indicator N. J0670 is billed in units of 10 ML; the quantity administered, the NDC package and the units on the claim must reconcile, which is the check that prevents CARC 16 and 151 returns on this line. The ASP crosswalk maps 11 NDCs to it, sold as Polocaine, Polocaine-Mpf, Polocaine - Mpf by A-S Medication Solutions, HF Acquisition Co. LLC, DBA HealthFirst, FreseniUS Kabi USA, LLC. It is the bundled column-2 code in 1,548 NCCI pairs, most often with 0345T, 0419T, 0420T. No current Billing and Coding Article lists J0670, so coverage follows the FDA label, compendia and any applicable NCD.

Medicare Part B payment limit (ASP)

CMS sets the Part B payment limit for J0670 at $4.367 per 10 ML for October 2026, derived from manufacturer average sales price plus 6%, compared with $4.147 in July 2026. Beneficiary coinsurance is 20%.

ASP payment limits for J0670
QuarterPayment limitPerCoinsurance
October 2026$4.36710 ML20%
July 2026$4.14710 ML—
Source: CMS Medicare Part B Drug Payment Limit File. Commercial and Medicaid payers set their own rates.

NDC to HCPCS billing-unit conversion

The October 2026 ASP crosswalk maps 11 NDCs from 3 labelers to J0670. Report the NDC in the claim's drug segment and bill the number of J0670 units that equals the quantity administered divided by 10 ML; the last column gives units per full package.

NDCs that crosswalk to J0670
NDCDrug nameLabelerPackage sizeBilling units / package
50090-4408-00PolocaineA-S Medication Solutions50 × 15
50090-4517-00PolocaineA-S Medication Solutions50 × 15
51662-1403-01Polocaine-MpfHF Acquisition Co. LLC, DBA HealthFirst30 × 13
51662-1403-03Polocaine - MpfHF Acquisition Co. LLC, DBA HealthFirst30 × 13
51662-1534-03PolocaineHF Acquisition Co. LLC, DBA HealthFirst50 × 25125
51662-1535-03PolocaineHF Acquisition Co. LLC, DBA HealthFirst50 × 25125
63323-0260-37Polocaine-MpfFreseniUS Kabi USA, LLC30 × 2575
63323-0283-57PolocaineFreseniUS Kabi USA, LLC50 × 25125
63323-0293-37Polocaine-MpfFreseniUS Kabi USA, LLC30 × 2575
63323-0294-27Polocaine-MpfFreseniUS Kabi USA, LLC20 × 2550
63323-0296-57PolocaineFreseniUS Kabi USA, LLC50 × 25125

Medically Unlikely Edits (MUE)

CMS publishes 3 MUE values for J0670. For practitioners the limit is 10 units per date of service with adjudication indicator 3, a date-of-service clinical edit: units above the limit deny but can be paid on appeal with documentation that the quantity was medically reasonable.

MUE values for J0670 by setting
SettingMUE (units/DOS)MAICMS rationale
Practitioner services103 Date of Service Edit: ClinicalClinical: Data
Facility outpatient hospital103 Date of Service Edit: ClinicalClinical: Data
DME supplier03 Date of Service Edit: ClinicalCMS Policy

MUE for J0670 in every setting opens the lookup with this code filled in, next to any other code on the same claim.

NCCI edits and add-on relationships

In the practitioner PTP file v323r0 (effective October 1, 2026), J0670 is the column-2 code in 1548 active pairs, 100% of which allow a modifier (indicator 1), and the column-1 code in 0. 141 historical pairs have been deleted over time. CMS's most frequent rationale: Misuse of Column Two code with Column One code.

When billed with these column-1 codes, J0670 is the bundled component unless the pair allows a modifier and the documentation supports a distinct service.

Column-1 codes most often paired with J0670
Column-1 codePairs
0345T (CPT; descriptor licensed by AMA)1
0419T (CPT; descriptor licensed by AMA)1
0420T (CPT; descriptor licensed by AMA)1
0446T (CPT; descriptor licensed by AMA)1
0447T (CPT; descriptor licensed by AMA)1
0448T (CPT; descriptor licensed by AMA)1
0483T (CPT; descriptor licensed by AMA)1
0484T (CPT; descriptor licensed by AMA)1
0490T (CPT; descriptor licensed by AMA)1
0505T (CPT; descriptor licensed by AMA)1

The counts above are exposure, not answers for a specific claim. Check J0670 against another code to see whether a given pair bundles, which code is paid and whether a modifier can separate them.

J0670 is neither an add-on code nor a designated primary code in the 2026 Q4 NCCI add-on edit file.

Medicare coverage articles

No current Billing and Coding Article lists J0670 in its HCPCS table. Coverage then follows the drug's FDA label, compendia and any National Coverage Determination; check the Medicare Coverage Database before administering off-label.

Hospital outpatient (OPPS) status

In the October 2026 OPPS Addendum B, J0670 carries status indicator N. Status N means payment is packaged into the associated procedure and no separate OPPS payment is made.

Ambulatory surgical center (ASC) payment

In the October 2026 ASC Addendum BB (covered ancillary services), J0670 carries payment indicator N1, which CMS defines as "Packaged service/item; no separate payment made". An N1 drug is packaged in the ASC: the facility receives no separate payment because the surgical procedure's rate already includes it.

Common denials for J0670 and how to prevent them

NDC missing, invalid or not matched to the HCPCS code

units billed exceed the MUE for the date of service

diagnosis not covered by the applicable coverage article or LCD

For teams evaluating QuickIntell software

Evaluate a coding workflow for J0670

Use the unit, NDC and edit questions in this reference to scope a QuickCode evaluation for qualified coder review, documentation clarification and the billing handoff. Confirm supported code sets, data inputs and reviewer responsibilities; the reference tables do not establish that a particular automated check or payer integration is available.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — HCPCS J0670

What does HCPCS code J0670 describe?

J0670 is defined by CMS as "Injection, mepivacaine hydrochloride, per 10 ml". Each billing unit represents 10 ML, so the units reported on the claim must equal the dose administered divided by that unit.

Is J0670 a CPT code?

No. J0670 is a HCPCS Level II code, the letter-plus-four-digit set CMS maintains for drugs such as mepivacaine hydrochloride; CPT codes are five-character codes maintained by the AMA. On a Part B claim J0670 reports the drug itself in 10 ml units, and the administration is billed on its own line.

What is the Medicare reimbursement for J0670 in October 2026?

The ASP-based payment limit is $4.367 per 10 ML, with 20% beneficiary coinsurance. The July 2026 limit was $4.147. Commercial payers use their own fee schedules.

How many units of J0670 can be billed per day?

The practitioner Medically Unlikely Edit is 10 units per date of service with adjudication indicator 3 (Date of Service Edit: Clinical). MAI 3 edits can be appealed with documentation that the units were medically reasonable. CMS cites "Clinical: Data" as the rationale.

Which NDCs map to J0670?

The October 2026 ASP crosswalk lists 11 NDCs from 3 labelers: Polocaine (A-S Medication Solutions); Polocaine-Mpf (HF Acquisition Co. LLC, DBA HealthFirst); Polocaine - Mpf (HF Acquisition Co. LLC, DBA HealthFirst); Polocaine (HF Acquisition Co. LLC, DBA HealthFirst). For example NDC 50090-4408-00 (package size 50) equals 5 billing units of J0670.

Does J0670 have NCCI bundling edits?

In the v323r0 practitioner PTP file, J0670 appears as the column-2 (bundled) code in 1548 active pairs and as the column-1 code in 0. 100% of the column-2 pairs allow a modifier (indicator 1). The most frequent column-1 partners are 0345T, 0419T, 0420T, 0446T, 0447T, and CMS's leading rationale is "Misuse of Column Two code with Column One code".

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page is an operational reference compiled from CMS publications: the Medicare Part B drug payment limit and NDC crosswalk files, NCCI MUE and add-on edit tables, aggregate PTP statistics, OPPS Addendum B, ASC Addendum BB and the Medicare Coverage Database. Payment limits and rates are Medicare national amounts; commercial and Medicaid payers differ. CPT codes are shown as numbers only; CPT descriptors are copyright AMA. Nothing here is legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.